StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by KPOIndustrieson Apr 14, 2020 9:19am

60 Views

Post# 30906654

RE:RE:Where is the test update? Progress...

They can't tell us anything until the product is ready to be released? That's BS, go to any other companies page and review their news updates. They provide SOMETHING at various stages of the production and approval cycle. All we know is that these guys are thinking about talking to the government about testing. Guess what... so is every company that is remotely close to anything COVID related.... as an investor, I want to hear that they have at least begun the process or that they have LOIs set up to manufacture and distribute. We don't know ANYTHING. But hey, I'm a basher, right. Care to enlighten everyone what more we know??? StageZero has failed to do that, thus far.